Article Information
History
- October 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Dennis Gürgen1,
- Theresia Conrad1,
- Michael Becker1,
- Susanne Sebens2,
- Christoph Röcken3,
- Jens Hoffmann1 and
- Stefan Langhammer4,*
- 1EPO Experimental Pharmacology & Oncology, Berlin, Germany
- 2Institute for Tumorbiology, University of Kiel, Kiel, Germany
- 3Institute for Pathology, University of Kiel, Kiel, Germany
- 4life science consulting, Burgwedel, Germany
- ↵*corresponding author; email: langhammer{at}ls-consultant.net